obesity drug news today glp-1 2025 oct 27 Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine 2025 ADA Highlights: A New
Description
The key is choosing a provider who monitors your progress with lab work and follow-up visits, not one that just ships medication
Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective
The impact on glycaemic management is most significant for diabetics (either type 1 or 2) who require insulin given most of the carbohydrates in clear fluids are simple sugars
The FAERS database has become the most widely used ADR database in recent years
10.1001/jama.2021.23619 [DOI] [PMC free article] [PubMed] [Google Scholar] 28
North America led the market by securing a market share of 49.7% in 2024
